Randy Yeates, Director of Business Development UI Pharmaceuticals presents at the ISPE Sterile Processing meeting in 2020

University of Iowa Pharmaceutical client update: Lixte enrolls first two patients for the investigational drug LB-100 for malignant brain tumor trial

UI Pharmaceuticals 16000 sq feet new-state-of-the-art sterile manufacturing facility featured in IowaNow article

Update: UI Pharmaceuticals 16,000 sq feet new-state-of-the-art sterile manufacturing facility

UI Pharmaceuticals featured in The Daily Iowan

Additional Dissolution Testing Units

Staffing Increased

CeleCor Therapeutics, Inc. & UI Pharmaceuticals Collaboration

Freund-Vector Hosts Solid Dosage Forms Seminar

UI Pharmaceuticals Collaborates with Rowpar Pharmaceuticals, Inc.